Robert M Kunemund
Examiner (ID: 4089)
Most Active Art Unit | 1714 |
Art Unit(s) | 1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763 |
Total Applications | 3442 |
Issued Applications | 2671 |
Pending Applications | 149 |
Abandoned Applications | 593 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17342171
[patent_doc_number] => 20220008502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => Method to Treat Alzheimer`s Disease
[patent_app_type] => utility
[patent_app_number] => 17/369681
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369681 | Method to treat Alzheimer's disease | Jul 6, 2021 | Issued |
Array
(
[id] => 17336015
[patent_doc_number] => 20220002346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PEPTIDE-PEPTOID SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 17/366822
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366822 | Peptide-peptoid scaffolds | Jul 1, 2021 | Issued |
Array
(
[id] => 17299468
[patent_doc_number] => 20210395307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => PEPTIDE THAT REGULATES FAT METABOLISM AND METHOD FOR REGULATING FAT METABOLISM
[patent_app_type] => utility
[patent_app_number] => 17/359370
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359370 | Peptide that regulates fat metabolism and method for regulating fat metabolism | Jun 24, 2021 | Issued |
Array
(
[id] => 19242021
[patent_doc_number] => 12012440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Compositions and methods for treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 17/358828
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7006
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358828
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358828 | Compositions and methods for treatment of fungal infections | Jun 24, 2021 | Issued |
Array
(
[id] => 17814330
[patent_doc_number] => 11419919
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-08-23
[patent_title] => High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/357255
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8330
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357255 | High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof | Jun 23, 2021 | Issued |
Array
(
[id] => 17156115
[patent_doc_number] => 20210317166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => ANTI-INFLAMMATORY USE OF PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/350795
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350795 | Anti-inflammatory use of peptide | Jun 16, 2021 | Issued |
Array
(
[id] => 18643285
[patent_doc_number] => 11767345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Antiviral peptide and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/329418
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 7953
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/329418 | Antiviral peptide and use thereof | May 24, 2021 | Issued |
Array
(
[id] => 17241810
[patent_doc_number] => 20210361553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => SKIN CARE PRODUCT WITH PROTEIN MATRIX
[patent_app_type] => utility
[patent_app_number] => 17/323421
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323421
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323421 | Skin care product with protein matrix | May 17, 2021 | Issued |
Array
(
[id] => 19473884
[patent_doc_number] => 12103960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => VEGF traps and mini-traps and methods for treating ocular disorders and cancer
[patent_app_type] => utility
[patent_app_number] => 17/314503
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 68
[patent_no_of_words] => 21495
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314503 | VEGF traps and mini-traps and methods for treating ocular disorders and cancer | May 6, 2021 | Issued |
Array
(
[id] => 17082054
[patent_doc_number] => 20210277060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => 14-3-3 TARGETING PEPTIDES FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/314795
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314795 | 14-3-3 targeting peptides for cancer treatment | May 6, 2021 | Issued |
Array
(
[id] => 17213125
[patent_doc_number] => 20210346461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => UTILIZATION OF ENDOGENOUS OUBAIN-REGULATING COMPOUNDS AND COMPOSITIONS THEREOF IN TREATMENT OF VASCULAR DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/313985
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313985 | UTILIZATION OF ENDOGENOUS OUBAIN-REGULATING COMPOUNDS AND COMPOSITIONS THEREOF IN TREATMENT OF VASCULAR DISEASE | May 5, 2021 | Pending |
Array
(
[id] => 17022609
[patent_doc_number] => 20210246480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => CELL HYDROLYSATE COMPOSITION FROM CULTIVATED CELLS AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/243493
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17243493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/243493 | Cell hydrolysate composition from cultivated cells and applications thereof | Apr 27, 2021 | Issued |
Array
(
[id] => 17183683
[patent_doc_number] => 20210330568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => TOPICAL COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/302057
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302057
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302057 | TOPICAL COSMETIC COMPOSITIONS | Apr 21, 2021 | Pending |
Array
(
[id] => 17170377
[patent_doc_number] => 20210324047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => ANTIVIRUS PROTEINS HAVING A KRINGLE 5 SUBUNIT
[patent_app_type] => utility
[patent_app_number] => 17/235652
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/235652 | Antivirus proteins having a Kringle 5 subunit | Apr 19, 2021 | Issued |
Array
(
[id] => 17168778
[patent_doc_number] => 20210322448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => CER-001 THERAPY FOR TREATING KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/231659
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231659 | CER-001 therapy for treating kidney disease | Apr 14, 2021 | Issued |
Array
(
[id] => 17052209
[patent_doc_number] => 20210261643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => INHIBITORS OF P-TEFB MEDIATED TRANSCRIPTION
[patent_app_type] => utility
[patent_app_number] => 17/220152
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/220152 | INHIBITORS OF P-TEFB MEDIATED TRANSCRIPTION | Mar 31, 2021 | Pending |
Array
(
[id] => 17897047
[patent_doc_number] => 20220306709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => AMPHIPHYSIN-I MUTANT HAVING ANTI-SENESCENCE ACTIVITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/211808
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17211808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/211808 | Amphiphysin-I mutant having anti-senescence activity and use thereof | Mar 23, 2021 | Issued |
Array
(
[id] => 17398167
[patent_doc_number] => 20220040257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/198034
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198034 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES | Mar 9, 2021 | Pending |
Array
(
[id] => 17080632
[patent_doc_number] => 20210275638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => POLYHEDRIN-BASED SLOW RELEASE GROWTH FACTOR SYSTEM FOR NEUROPROTECTION OF RETINAL GANGLION CELL NEURONS
[patent_app_type] => utility
[patent_app_number] => 17/192328
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/192328 | POLYHEDRIN-BASED SLOW RELEASE GROWTH FACTOR SYSTEM FOR NEUROPROTECTION OF RETINAL GANGLION CELL NEURONS | Mar 3, 2021 | Pending |
Array
(
[id] => 18171765
[patent_doc_number] => 11571458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health
[patent_app_type] => utility
[patent_app_number] => 17/187535
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 24957
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187535
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187535 | Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health | Feb 25, 2021 | Issued |